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ABSTRACT
LlaGI is a single polypeptide restriction–
modification enzyme encoded on the naturally-
occurring plasmid pEW104 isolated from
Lactococcus lactis ssp. cremoris W10. Bioinfor-
matics analysis suggests that the enzyme contains
domains characteristic of an mrr endonuclease,
a superfamily 2 DNA helicase and a c-family
adenine methyltransferase. LlaGI was expressed
and purified from a recombinant clone and its
properties characterised. An asymmetric recogni-
tion sequence was identified, 50-CTnGAyG-30
(where n is A, G, C or T and y is C or T). Methylation
of the recognition site occurred on only one strand
(the non-degenerate dA residue of 50-CrTCnAG-30
being methylated at the N6 position). Double
strand DNA breaks at distant, random sites were
only observed when two head-to-head oriented,
unmethylated copies of the site were present;
single sites or pairs in tail-to-tail or head-to-tail
repeat only supported a DNA nicking activity.
dsDNA nuclease activity was dependent upon the
presence of ATP or dATP. Our results are consistent
with a directional long-range communication mech-
anism that is necessitated by the partial site
methylation. In the accompanying manuscript
[Smith et al. (2009) The single polypeptide
restriction–modification enzyme LlaGI is a self-
contained molecular motor that translocates DNA
loops], we demonstrate that this communication is
via 1-dimensional DNA loop translocation. On the
basis of this data and that in the third accompanying
manuscript [Smith et al. (2009) An Mrr-family
nuclease motif in the single polypeptide
restriction–modification enzyme LlaGI], we pro-
pose that LlaGI is the prototype of a new sub-
classification of Restriction-Modification enzymes,
named Type I SP (for Single Polypeptide).
INTRODUCTION
LlaGI is a restriction–modiﬁcation (RM) enzyme isolated
from Lactococcus lactis ssp. cremoris W10 (1,2). It is
encoded on the epigenetic element pEW104 and comprises
the fusion of four putative protein domains (Figure 1A
and B): an mrr-family nuclease (3,4); a Superfamily 2
(SF2) helicase (1; a g-type adenine methyltransferase
(MTase) (1); and a target recognition domain (TRD)
(1). Comparing the LlaGI primary amino acid sequences
to the bacterial and archaeal sequences currently listed in
the REBASE database (2) identiﬁes 69 additional single
polypeptide, helicase-containing RM enzymes (Table 1).
Of these, two distinct groupings were noted on the basis
of characteristic Walker A box sequences in their helicase
domains: those with a GTGKT sequence which includes
LlaGI (56 members) and those with an RFGKT sequence
(14 members). Studies of Lactococcus bacteriophage infec-
tion show that LlaGI has eﬃcient RM activity, producing
at least a thousand-fold decrease in infectivity (1).
However, details of the reaction mechanism of LlaGI, or
any of the related enzymes, are not known. Whilst
helicase-nuclease domain fusions are also found in the
ATP-dependent Type I and Type III RM enzymes (5,6),
and nuclease-MTase domain fusions are typical to many
sub-classes of Type II RM enzymes (7–9), the fusion of all
three elements is unique to LlaGI and related enzymes.
Thus LlaGI can be considered the prototype of a new
sub-type of RM enzymes. On the basis of similarities in
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Josephsen (1) suggested that LlaGI is a variant of the
Type I RM enzymes. Here, and in the accompanying
papers (10,11), we provide an in-depth biochemical
analysis of the in vitro enzymatic activities of LlaGI. On
the basis of this data we discuss below the relationship of
LlaGI to other RM enzymes of Types I, II and III, and
suggest a suitable familial classiﬁcation that is consistent
with both domain organisation and function.
MATERIALS AND METHODS
DNA
All oligonucleotides were supplied by MWG biotech
(Germany). Plasmid pOne is pUC19 (12), and is
re-named here for clarity. pZero was derived from pOne
by QuikChange mutagenesis (Stratagene, La Jolla, CA)
using primers 50-CCCGGCAACAATTAATAGATTGG
ATGGAGGCGGATAAAGTTGC-30 and 50-GCAACTT
TATCCGCCTCCATCCAATCTATTAATTGTTGCCG
GG-30 (where the LlaGI sequence is highlighted in bold
and the mutated base pair underlined). The library of two-
site plasmids (Figure 3) was generated by directional
cloning of duplex oligonucleotides into the XbaI/HindIII
fragment of plasmid pOne. One strand of each duplex
oligonucleotide is shown in Figure 3B (white background).
Where the sites are in direct repeat (where the ‘top strand’
sequences in Figure 3 are on the same DNA strand), the
plasmids are named pHT for head-to-tail. Where the sites
are in indirect repeat, the plasmids are named pHH for
head-to-head (note that these DNA have sites in both
head-to-head and tail-to-tail orientation). The sequence
of Site b is denoted by a numeric suﬃx (1–14), Site a
being constant (Figure 3B). Linear DNA substrates
for the site identiﬁcation experiments were produced
by PCR using Pfu polymerase as directed by the manu-
facturer’s recommendations. Sequences of the primers
used are available from M.D.S. on request.
pRSFLlaGI was generated as follows: The llagiRM
gene was ampliﬁed from pEW104 (1) by PCR using
oligonucleotides 50-GCGTAAGTCCCATGGTGGCATT
TTGGAAGG-30 and 50-GCGTAAGTCGGATCCTTAT
TCTTGAATTTCAAATTCTGGTAA-30; The PCR
product was digested with NcoI and BamHI and
inserted into pETDuet-1 (Novagen, Germany) digested
with NcoI and BglII; The NcoI-XhoI fragment containing
the llagiRM gene was then inserted into pRSFDuet-1
(Novagen, Germany); The llagiRM gene was fully
sequenced. pET28OrfX was generated as follows: The
orfx gene was ampliﬁed from pEW104 by PCR using
oligonucleotides 50-CGAGCCCATATGATGAGTGAA
AAGTTAAAG-30 and 50-CTAGCTCTCGAGTCATTT
TACATTCCTTCC-30; The PCR product was digested
with NdeI and XhoI and inserted into pET28a (Novagen,
Germany); The his6-orfX gene was fully sequenced.
To prepare DNA for biochemical assays, E. coli Top10
(Invitrogen, CA, USA) or XL10-Gold (Stratagene) were
transformed with the required plasmid, grown in LB
medium and the DNA extracted using either commercial
protocols (Qiagen, Hilden, Germany) or by density
gradient centrifugation in CsCl-ethidium bromide (13).
For experiments requiring
3H-labelled DNA, transfor-
mants were grown in M9 minimal medium supplemented
with 37MBq/l [
3H-methyl] thymidine. Linear DNA
substrates were generated by incubating 4nM plasmid
DNA with 1U/ml of AlwNI or 2U/ml of NdeI in
NEBuﬀer 2 (New England Biolabs, MA, USA). The
DNA was puriﬁed by phenol/chloroform and chloroform
extraction followed by ethanol precipitation. DNA
concentrations were determined from UV absorbance at
260nm, assuming that an optical density of 1 corresponds
to 50mg/ml DNA and a molecular weight of 6.6 10
5
Da/kb.
Protein expression and puriﬁcation
Wild type LlaGI was puriﬁed from E. coli BL21 (DE3)
cells (Novagen, Germany) and transformed with
pRSFLlaGI. Cultures were grown in 4L of LB medium
containing kanamycin (50mg/ml) at 37 C and 250r.p.m.
until the OD600 reached  0.4. IPTG was added to 1mM
and the cultures were incubated further at 27 C for an
hour (ﬁnal OD600 of  1.0). Cells were harvested,
re-suspended in 45ml of Buﬀer A [50mM Tris–Cl (pH
8.0), 150mM NaCl, 5mM MgCl2, 2.5mM EDTA, 10%
(v/v) Glycerol, 3mM DTT, 51.7mM phenylmethylsulfonyl
ﬂuoride, and EDTA free protease inhibitor tablets
according to the manufacturer’s instructions (Roche,
UK)] and lysed using a cell disruptor (Constant Systems
Ltd, Northants, UK). The cell extract was clariﬁed by
centrifugation at 7358g for 10min followed by 106255g
for 1h 50min. The supernatant was dialysed against
Table 1. LlaGI-like sequences identiﬁed from REBASE (2)
GTGKT subgroup (56 sequences)
AauTCORF264P CdpORF453P LlaSKORF6P
AavORF578P CglORF3009P LmoDORFAP
AspFBORF4323P CsyMAORFGP MboAORF2049P
AviDJORF22890P DvuORF2175P MboBCGORF2043P
BfrYORF1980P EsaRM24P MboBCGTORF2038P
BheHORF15450P GthNGORF2804P MpePMORF102P
BovEORF2337P HacSORF1335P MspELB17ORFDP
BtrCIPORF1006P Hpy99ORF612P MtuCTORF2082P
BtrCIPORF1021P HpyAORF668P MtuFORF12055P
BtrCIPORF1035P HpyGORF629P Mxa6833447ORFDP
BtrCIPORF1053P HpyHORF652P Mxa6833447ORFFP
BtrCIPORF1064P HpyPORF680P MxaDKORF1808P
BtrCIPORF1080P HpySORF3515P NeuCORF2561P
BtrCIPORF1105P Hso2336ORF1665P NfaORF2220P
BtrCIPORF14P LbiPAORF5032P Pdi8503ORF1520P
BtrCIPORF164P LbiPORF33P PsyTORF37P
BtrCIPORF2491P LinCORF21P RspKDORF4062P
BtrCIPORF455P LlaBIII Tha33315P
BtrCIPORF541P LlaGI
RFGKT subgroup (14 sequences)
BthAHORF843P LdeBBORF1654P PpeRS5ORF3P
BthVORF4013P LlaBIIP Sth1066ORF1376P
DolHORF905P NspJCORF1588P Sth18311ORF1376P
LacORF475P PgiCORF415P SthLMDORF13303P
Lbr367ORF22P PgiTORF1696P
Two distinct subgroups were observed with distinct sequences at
helicase Motif I (the Walker A box). Note that some of these sequences
have N-terminal deletions and/or mutations that may result in an
inactive nuclease.
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NaCl, 1mM DTT], 0.45 mm ﬁltered and loaded onto two
20ml HiPrep Heparin 16/10 FF columns (GE Healthcare
UK Ltd) connected in series and equilibrated in Buﬀer
B. Bound proteins were eluted with a linear gradient of
NaCl in Buﬀer B (0.05–1.0M, 400ml). LlaGI was eluted
at  0.40M NaCl. Fractions containing LlaGI were
pooled and, concentrated and equilibrated into Buﬀer B
using 50kDa cut-oﬀ centrifugal ﬁlter units (Millipore,
MA, USA). The resulting sample was loaded onto an
8ml Mono Q 10/10 column (GE Healthcare) pre-
equilibrated with Buﬀer B. Bound proteins were eluted
with a linear gradient of NaCl in Buﬀer B (0.05–1.0M,
160ml). LlaGI eluted at  0.38M NaCl. Fractions con-
taining LlaGI were pooled and concentrated as above.
The resulting sample was further puriﬁed over a HiLoad
16/60 Superdex 200pg column (GE Healthcare) pre-
equilibrated in Buﬀer B containing 400mM NaCl.
Fractions containing LlaGI were pooled and concentrated
as above, supplemented with glycerol to 50% (v/v) and
stored at  20 C. The protein concentration was deter-
mined by the Bradford dye-binding procedure (Bio-Rad
Protein Assay, Bio-Rad, Hemel Hempstead, UK) using
bovine serum albumin (BSA) as standard. Similar concen-
trations (within experimental error) were determined by
UV absorption at 280nm using an extinction coeﬃcient
derived from the aromatic amino acid composition of the
predicted amino acid sequences. The production and puri-
ﬁcation of the LlaGI nuclease mutant DA078 is described
in the accompanying paper (11).
His6-tagged OrfX was puriﬁed from E. coli Tuner
(DE3) cells (Novagen) transformed with pET28OrfX.
Cultures were grown in 1L LB medium containing
50mg/ml kanamycin at 37 C and 250r.p.m. until the
OD600 reached  0.4. IPTG was added to 25mM and the
cultures were incubated for a further 4h at 37 C (ﬁnal
OD600 of  4.5). Cells were harvested, re-suspended in
45ml of Buﬀer C [50mM Tris–Cl (pH 8.0), 200mM
NaCl, 10mM Imidazole, 11.1mg/ml lysozyme], incubated
on ice for 10min, and then lysed by cell disruption
(as above). The cell extract was clariﬁed by centrifugation
at 7358g for 10min followed by 106255g for 37min. The
supernatant was 0.45 mm ﬁltered, loaded onto a 5ml
HiTrap Chelating column that had been charged with
NiSO4 (GE Healthcare), and washed in Buﬀer C. Bound
proteins were eluted with a linear gradient of Imidazole in
Buﬀer C (0.01–0.5M, 50ml). Fractions containing OrfX
were pooled, and diluted 10-fold with Buﬀer B. The
resulting sample was then loaded onto a 1ml Mono Q
5/50 GL column (GE Healthcare) pre-equilibrated with
Buﬀer B. Bound proteins were eluted with a linear
gradient of NaCl in Buﬀer B (0.05–1.0M, 20ml). OrfX
was eluted at  0.25M NaCl. Fractions containing OrfX
were pooled and dialysed against Buﬀer D [50mM Tris–Cl
(pH 8.0), 500mM NaCl, 10mM Imidazole]. The sample
was then added to 20mg Protino Ni-IDA Resin
(Macherey-Nagel) and incubated at 4 C for 1h. The
beads were washed three times in Buﬀer D to remove
unbound protein. OrfX was eluted in Buﬀer E [50mM
Tris–Cl (pH 8.0), 500mM NaCl, 500mM Imidazole] and
then dialysed into Buﬀer B containing 400mM NaCl.
OrfX was supplemented with glycerol to 50% (v/v) and
stored at  20 C. The protein concentration was deter-
mined by the Bradford dye-binding procedure using
BSA as a standard.
EcoAI and EcoR124I methyltransferases (denoted
by the preﬁx M) and HsdRs (denoted by the preﬁx R)
were puriﬁed and characterised as described previously
(data not shown) (14).
Gel ﬁltration and N-terminal sequencing
N-terminal sequencing of LlaGI was carried out in-house
at the Proteomics Facility. Analytical gel ﬁltration was
carried out using a 24ml Superose 6 column (GE
Healthcare). The column was pre-equilibrated at 0.4ml/
min with TMD buﬀer [50mM Tris–HCl (pH 8.0), 10mM
MgCl2, 1mM DTT] supplemented with 15mM NaCl. A
100 ml loop was ﬁlled with protein sample in storage buﬀer
[30mM Tris–Cl (pH 8.0), 0.6mM EDTA, 240mM NaCl,
0.6mM DTT, 50% (v/v) glycerol]. LlaGI was eluted
with TMD plus 15mM NaCl at 0.4ml/min and monitored
by measuring the absorbance at 280nm. The Superose
column was calibrated using thyroglobulin (669kDa),
apoferritin (443kDa), b-amylase (200kDa), alcohol
dehydrogenase (150kDa), BSA (66kDa) and carbonic
anhydrase (29kDa). Blue dextran was used to calculate
the void volume.
DNA cleavage assays
Cleavage assays contained 4nM DNA (supercoiled or
linear), 4mM ATP (or other nucleotide where indicated)
and LlaGI (at the concentrations indicated) in TMD
buﬀer. Where included, S-adenosyl methionine
(AdoMet) was at 100mM. Reactions were started by
adding LlaGI to a mix of ATP, DNA and AdoMet
(where present) in TMD buﬀer and incubated at 20 C
for the times indicated. Other Type II RM endonucleases
were added at concentrations recommended by the
suppliers. Reactions were stopped with 0.5 volumes of
3  STEB [0.1M Tris (pH 7.5), 0.2M EDTA, 40% (w/v)
sucrose, 0.4mg/ml bromophenol blue]. Samples were
analysed by agarose gel electrophoresis and, the percent-
age of
3H-labelled DNA in each band per lane was ascer-
tained by scintillation counting (13), where required.
DNA methylation assays
Competition assays using EcoAI and EcoR124I. As
indicated, 4nM pHH-7 was methylated with 200nM
LlaGIDA078 (11), 40nM M.EcoAI (14) or 100nM
M.EcoR124I (14) in TMD buﬀer supplemented with
4mM ATP and 100mM AdoMet. For methylation by
M.EcoAI, the TMD buﬀer was supplemented with
50mM NaCl. The reactions were incubated for 4h
on ice, at 20 C, at 25 Co ra t3 7  C for untreated,
LlaGIDA078, M.EcoAI or M.EcoR124I, respectively.
Additional AdoMet was added after 1, 2 and 3h and addi-
tional enzyme, where required, was added after 2h. To
each sample 0.1 volumes of 0.5M EDTA was added and
the DNA puriﬁed in three steps: (i) phenol/chloroform
extraction and ethanol precipitation; (ii) by Qiagen PCR
kit; and (iii) phenol/chloroform extraction and ethanol
7208 Nucleic Acids Research, 2009,Vol.37, No. 21precipitation. The untreated and methylated DNA were
then mixed with 4mM ATP and 100mM AdoMet in
TMD buﬀer (supplemented with 50mM NaCl for the
EcoAI reactions), in the presence or absence of: 200nM
LlaGI; 400nM M.EcoAI and 600nM R.EcoAI; or, 40nM
M.EcoR124I and 300nM R.EcoR124I. The reactions
were incubated for 10min on ice, at 20 C, at 25 Co ra t
37 C for no enzyme, LlaGI, EcoAI and EcoR124I, respec-
tively. The reactions were stopped by the addition of 0.5
volumes of 3x STEB containing 1mg/ml Proteinase K
and heated to 67 C for 20min. The DNA substrates and
products were separated by agarose gel electrophoresis.
Relative methylation of the eight LlaGI recognition
sequences. As indicated, 4nM DNA (pZero, pOne,
pHH-1, -2, -3, -6, -8, -9, -13, -14) and 200nM
LlaGIDA078 were incubated for 1h at 37 C in NEBuﬀer
4 supplemented with 4mM ATP and 100mM[
3H-methyl]
AdoMet. AlwNI (0.5U/ml) and NdeI (1U/ml) were added
to each tube and incubated further at 37 C for 1h. The
reactions were stopped by the addition of 0.1 volume 6x
STEB [0.2M Tris (pH 7.5), 0.4M EDTA, 80% (w/v)
sucrose, 0.8mg/ml bromophenol blue] and the DNA
fragments separated by agarose gel electrophoresis.
Fragment 1 containing Site a and Fragment 2 containing
Site b were quantiﬁed by scintillation counting. Gel back-
ground counts were subtracted from all samples. The
counts (dpm) from pZero fragment 1 (i.e. background)
were subtracted from the counts of all other fragment 1
bands, and the counts from pZero Fragment 2 (i.e. back-
ground) were subtracted from the counts of all other
Fragment 2 bands. The counts from each Fragment
were then divided by the counts from pOne Fragment 1.
The log2 of the resulting values were then calculated to
give a linear scale (see legend to Figure 7).
RESULTS
Site speciﬁcity of DNA cleavage by LlaGI
The earlier study of LlaGI identiﬁed a region of pEW104
encompassed by the SacI and NsiI restriction sites as
suﬃcient for in vivo RM activity (1). This region
contains three genes: repB, orfX and llagiRM that
appear to be co-transcribed from a single promoter
(Figure 1A). Whilst a similar gene arrangement is seen
in some enzymes that are closely related to LlaGI
(e.g. LlaBIII), it is not observed in other cases (e.g.
RM.GthNGORF2804P) (2). Genes within a single operon
may participate in a common metabolic pathway, but
this is not always the case: co-transcribed proteins often
simply perform broadly similar general functions, and
may even have completely unrelated functions (15,16).
repB produces a protein associated with plasmid replica-
tion (17). orfX is often found associated with repB and a
similar ORF has been identiﬁed in many lactococcal theta-
replicating plasmids (18–21). The precise function of the
orfX product remains mostly unknown: in some plasmids
it may participate in copy number, stability, or both
(19,21,22); however, it has been shown to be dispensable
for plasmid replication in other cases and is sometimes
completely absent (23). To determine whether the
product of the llagiRM gene alone was suﬃcient for site-
speciﬁc DNA recognition, methylation and cleavage, and
whether orfX participated in these processes, we produced
recombinant clones of native llagiRM and His-tagged
orfX (‘Materials and Methods’ section).
Native LlaGI was over-expressed and puriﬁed to >94%
homogeneity using a three column method (Figure 2A;
‘Materials and Methods’ section). (Induction of LlaGI
expression was carried out at 27 C to optimise enzyme
yield—data not shown). Analytical gel ﬁltration under
reaction buﬀer conditions (see below, ‘Materials and
Methods’ section) resulted in a single peak, suggesting a
single species. Using molecular weight standards to cali-
brate the column, we calculated an apparent MW
for LlaGI of 187kDa, similar to the predicted MW of
179kDa and consistent with a monomeric species. N-
terminal sequencing of the puriﬁed LlaGI indicated two
protein populations; full-length protein and a nine amino
acid N-terminal truncation (data not shown). These two
species could not be resolved by gel ﬁltration.
His-tagged OrfX was puriﬁed to >80% homogeneity
(data not shown; ‘Materials and Methods’ section). We
tested if the DNA cleavage pattern of LlaGI was altered
by the inclusion of the orfx gene product. No change in
DNA cleavage speciﬁcity was observed (data not shown)
and site-speciﬁc DNA cleavage, methylation and loop-
translocation were obtained using LlaGI in isolation [see
below and refs (10,11)]. We therefore ﬁnd no evidence that
the close association of llagiRM-related genes to repB-
and/or orxX-like genes reﬂects the participation of repB
and the orfX gene products in the LlaGI RM system.
However, the close linkage may still be important during
plasmid replication so that maintenance methylation and
replication are temporally linked.
To ascertain the recognition sequence of LlaGI we used
an in vitro approach similar to that used previously to
Figure 1. The LlaGI RM enzyme. (A) The SacI-NsiI region of
pEW104 identiﬁed previously as suﬃcient for in vivo RM activity (1).
The approximate locations of the putative promoter (P) and terminator
(T) of the operon are indicated. (B) The llagiRM gene product is a
single polypeptide, multi-domain protein (1). Protein domain
boundaries were estimated using secondary structure prediction and
alignment with LlaBIII (not shown). Target Recognition Domain
(TRD). (C) Recognition sequence of LlaGI. The adenine residue that
is methylated is indicated by a circle. The arrowhead deﬁnes
the directionality of the site according to cleavage (Figure 4) and
translocation assays (10). The ‘top strand’ sequence (i.e. that starting
with CT) is quoted throughout.
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trary DNA plasmids (data available from M.D.S. on
request) were screened for susceptibility to cleavage by a
>20-fold molar excess of LlaGI in the presence of ATP
(predicted to be a necessary co-factor because of the
presence of the helicase domain) (‘Materials and
Methods’ section). Cleavage activity was largely indepen-
dent of the buﬀer components and AdoMet was not oblig-
atory, although some stimulation of the cleavage reaction
was observed (see below and Figure 6). We did not note
any diﬀerences in the cleavage patterns when we tested
DNA puriﬁed from a dam
-/dcm
- strain (GM2929—ref.
25) (data not shown). Secondary cleavage with suitably
located Type II restriction enzymes revealed that
cleavage by LlaGI resulted in a smear of DNA fragments
of variable lengths reminiscent of the cleavage patterns of
Type I RM enzymes (see below) (26–28). We therefore,
assumed that LlaGI used a similar mechanism; i.e. DNA
cleavage occurs as the result of communication and
collision between two enzymes originating from two rec-
ognition sites located on either side of the cleavage loci.
Using primer walking, a library of PCR substrates was
then generated in which one end of the DNA was
iteratively shortened. These DNA substrates were tested
for dsDNA cleavage. When DNA cleavage activity was
lost, it was assumed that the recognition site was no
longer copied by the PCR and that the LlaGI site
resided in the region of DNA up to the previous primer
in the series. (As part of this process, we found that LlaGI
would not cut a DNA if its site was within 30bp of a free
DNA end; data not shown). Several DNA regions that
were indentiﬁed as containing a possible site were
analysed to identify common sequences of 6±1bp in
length. To make sense of our results we also had to
make the assumption that dsDNA cleavage only
occurred when the sites were found in an indirectly-
repeated orientation (the directionality of the site is
deﬁned in Figure 1C). This process identiﬁed the
sequence 50-CTnGAyG-30, giving a total of eight
possible LlaGI sequences.
To conﬁrm the recognition sequence, we created a
library of two-site DNA substrates using as the parental
plasmid pOne, which contained only one putative
sequence, named site a (Figure 3A, ‘Materials and
Methods’ section). The 14 DNA sequences tested were
designed to represent the eight variations of the putative
LlaGI site (i.e. all combinations of the degenerate
positions) and to also test variations in adjacent
non-speciﬁc sequence (Figure 3B). dsDNA cleavage
(as judged by the appearance of linear DNA) was only
observed when the pair of LlaGI sites were in an
indirectly-repeated orientation (Figures 3A and B). All
eight versions of the LlaGI site resulted in dsDNA
cleavage, with no measurable preference for any other
bases in the ﬂanking DNA sequences. Plasmids are
named hereafter with a numeric suﬃx (1–14) to indicate
the ‘top strand’ sequence of Site b (and adjacent DNA),
Site a being constant.
The recognition site requirements for DNA cleavage by
LlaGI are summarised in Figure 4. Cleavage of circular
plasmid DNA was not observed in the absence of a rec-
ognition site (pZero, Figure 4A and B). In the presence of
a single site (pOne), eﬃcient DNA nicking was observed
without the formation of linear DNA. In the presence of
two indirectly-repeated sites (pHH-3), dsDNA cleavage
resulted in the formation of linear DNA (also for
pHH-12 in Figure 4C and D). If the two sites were
directly repeated (pHT-12), only DNA nicking was
observed (Figure 4D), similar to the result on pOne. On
the pHH-3 and pHH-12 substrates, cleavage could result
from interactions between the sites via the head-to-head
and/or tail-to-tail DNA arcs. We therefore also generated
a series of linear DNA substrates in which the pair of
LlaGI sites were oriented either head-to-tail (HT), head-
to-head (HH) or tail-to-tail (TT), as deﬁned by the site
orientation in Figure 1C (Figure 4C). The plasmid DNA
was cut ﬁrst by a Type II RM enzymes (‘1st enzyme’, as
indicated) and then treated with LlaGI (‘2nd enzyme’, as
indicated) (Figure 4D). dsDNA cleavage by LlaGI was
only observed when the sites were in a head-to-head
Figure 2. Puriﬁcation and solution stoichiometry of LlaGI. (A) Lanes
from separate SDS polyacrylamide gels showing stages in the protein
puriﬁcation protocol. G.F., gel ﬁltration. The Post G.F. lane represents
5mg of puriﬁed RM.LlaGI. See ‘Materials and Methods’ section for full
details. (B) Elution proﬁle of 263mg (14.7mM) LlaGI from a 24ml
Superose 6 column. 100 ml of protein sample was eluted in TMD
Buﬀer plus 15mM NaCl at 0.4ml/min. Protein was monitored using
absorbance at 280nm. The elution volumes of the thyroglobulin
(669kDa) and carbonic anhydrase (29kDa) standards are indicated in
red. Indicated in blue are the putative elution volumes of a LlaGI
monomer and dimer assuming a theoretical MW of 179kDa (calculated
from the full length amino acid sequence). (Inset) The apparent molec-
ular weight of LlaGI was evaluated from the elution volume using a
series of standards (‘Materials and Methods’ section). The red line
indicates a least squares linear ﬁt.
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the linear DNA in this assay. The smear of DNA products
observed with the HH substrate had a size distribution
consistent with cleavage within the region between the
sites. A similar distribution of cleavage loci exclusively
in the HH DNA arc was also observed following
cleavage of plasmid DNA (data not shown).
Nucleotide-dependence of the DNA cleavage
activity of LlaGI
Using the two-site plasmid pHH-3, we tested the
nucleotide-dependence of the cleavage reaction
(Figure 5). LlaGI was incubated with
3H-labelled pHH-3
for 10min under the conditions indicated, and the relative
levels of substrate (CC), intermediate (OC) and full length
linear product (FLL) quantiﬁed (‘Materials and Methods’
section). Eﬃcient dsDNA cleavage was only observed in
the presence of either ATP or dATP. In the complete
absence of nucleotide, incomplete DNA nicking was
observed. This nicking activity was stimulated moderately
by ATPgS and CTP, but still at a reduced level compared
to the activity with ATP or dATP. All subsequent assays
here and in the accompanying manuscripts (10,11) were
carried out with ATP.
Rate and stoichiometry of DNA cleavage by LlaGI
The reactions above used an excess of LlaGI over DNA
and were incubated until no further DNA cleavage
occurred (reaction time of  10min). To assess further
the DNA cleavage mechanism of LlaGI, we measured
the extent of DNA cleavage at the reaction ‘end point’
as a function of the LlaGI:DNA molecular ratio and
measured the rate of one- and two-strand DNA cleavage
at a saturating concentration of LlaGI. The eﬀect of the
MTase cofactor AdoMet was assessed in each case.
Cleavage stoichiometry. Titration of LlaGI with
3H-
labelled pHH-3 in the absence of AdoMet is shown in
Figure 6A. Complete DNA cleavage (as judged by the
appearance of >90% FLL DNA) was only obtained
with >10 LlaGI molecules per DNA molecule (ﬁve
monomers per site). Below this concentration, nicked
DNA accumulated. At the highest enzyme concentrations
examined the linear DNA was further processed to
produce a smear. The distribution of the DNA products
indicates an exonuclease activity. A similar reaction
proﬁle was observed in the presence of AdoMet except
that complete DNA cleavage was obtained with >5
LlaGI monomers per DNA molecule (two to three
monomers per site) (Figure 6B). In addition to its role
as a methyl donor, AdoMet has been widely demonstrated
to have a second role for methyltransferases as an
allosteric activator of DNA binding (29,30). The data in
Figure 6B is consistent with such a role in LlaGI. The
exonucleolytic processing of the linear product DNA
also occurred at lower protein concentrations with
AdoMet (note, this produces an artiﬁcial increase in the
CC substrate—see legend to Figure 6).
A requirement for multiple LlaGI molecules per site can
be explained by a number of diﬀerent models which are
not mutually exclusive: (i) dsDNA cleavage requires the
interaction of multiple LlaGI molecules. For example, a
requirement for a dimer of LlaGI at each recognition site
would be consistent with the data in Figure 6B; (ii) The
DNA-binding aﬃnity is relatively low under our reaction
conditions; or (iii) the proportion of inactive LlaGI in our
preparations is relatively high (i.e. a low speciﬁc activity).
Titration of LlaGI with
3H-labelled pHT-12 in the
absence of AdoMet is shown in Figure 6C. Full DNA
nicking activity (>80% OC produced) was observed
with >2 LlaGI molecules per site. Full nicking activity
Figure 3. Cleavage of LlaGI recognition sequences. (A) A library of two-site DNA substrates were generated from pOne (Figure 4) by cloning
diﬀerent LlaGI sequences (Site b – see B). Site a was constant in each case. For three of the sequences both directly-repeated and indirectly-repeated
copies of Site b were tested. Example agarose gel shown where CC is Covalently closed Circular substrate DNA, OC is Open Circle nicked
intermediate and FLL is the Full Length Linear product cleaved in both strands. DNA and LlaGI were incubated for 10min. (B) Sequences of
sites tested with outcome for indirectly-repeated (HtH) and directly-repeated (HtT) arrangements of sites: C, dsDNA cleavage; N, nicking only; n.d.,
not determined. pOne sequence is highlighted in grey, cloned sequence in white, constant LlaGI sequence in yellow and degenerate positions in red
(dG), green (dA), blue (dC), purple (dT). Sequence shown is the ‘top strand’ as deﬁned in Figure 1C.
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6A). This suggests that the nicking of both plasmids
requires the same amount of LlaGI molecules per site
but that cleavage of the second strand of pHH-3 to
generate a dsDNA break requires additional enzyme
molecules. At the higher enzyme concentrations, the
nicked DNA band becomes smeared, producing an
apparent increase in the CC concentration because of
overlapping DNA mobilities.
Cleavage rate. A time course of pHH-3 cleavage in the
presence of excess LlaGI (25 per site) and in the absence
of AdoMet is shown in Figure 6D. The reaction proﬁle
shows that nicked DNA is a signiﬁcant intermediate in the
reaction, reaching a maximum of >50%. This is higher
than the  33% expected for a reaction in which each
strand cleavage rate is identical. This could arise
because, either the rate of the ﬁrst strand cleavage is
faster than the second or, the long-range communication
between the LlaGI sites collapses before both strand
cleavages can occur. We cannot distinguish between
these alternatives given our current data. In the presence
of AdoMet, the rate and proﬁle of DNA cleavage were
very similar (Figure 6E). Whilst AdoMet can enhance
protein–DNA interactions, once DNA binding is
saturated, AdoMet does not alter the reaction pathway.
The rate of DNA nicking of pHT-12 in the presence of
excess LlaGI and in the absence of AdoMet is shown
in Figure 6F. The nicking rate was  3-fold slower than
that observed on pHH-3 under the same conditions. The
diﬀerence in these values is consistent with a diﬀerent
cleavage pathway for sites in direct or indirect repeat.
Site speciﬁcity of DNA methylation by LlaGI
The amino acid sequence of the MTase domain of LlaGI
has an arrangement of catalytic motifs consistent with the
adenine-speciﬁc g sub-family (1,31). The eight LlaGI rec-
ognition sequences (Figures 1C and 3B) contain two
invariant adenine residues, one on each strand, which
are potential targets for methylation. In some sites
adenine residues also occur at the degenerate positions
and it is possible that these are also targets for modiﬁca-
tion. We ﬁrst tested the invariant adenine residues. One of
the two-site indirectly repeated plasmids described earlier
(pHH-7) had been designed such that site b overlaps with
Figure 4. DNA site requirements for cleavage by LlaGI. (A and B)
Plasmid substrates with no sites, one-site or two indirectly-repeated
sites were incubated with either saturating BamHI (B) or LlaGI (L)
for 1h. Substrates and products were separated by agarose gel
electrophoresis as indicated. (C and D) Plasmid substrates with two
directly-repeated sites (pHT-12) or two indirectly-repeated sites
(pHH-12) were cleaved with either AlwNI (A) or NdeI (N) to
produce the linear DNA indicated. Sequences of the LlaGI sites are
in Figure 3. The parental plasmids and linear DNA were then
incubated with saturating LlaGI for 1h. Substrates and products
were separated by agarose gel electrophoresis as indicated. See main
text for full details. Under these assay conditions, an additional slowly-
migrating band was observed which we assign to a LlaGI-DNA
bandshift. Gels labelled as in Figure 3.
Figure 5. Nucleotide dependence of DNA cleavage by LlaGI. Error
bars represent standard errors from at least two repeat experiments.
pHH-3 was incubated with excess LlaGI for 10min in the absence or
presence of 4mM nucleotide, as indicated. Reaction products were
separated by agarose gel electrophoresis and the extent of DNA
cleavage quantiﬁed (‘Materials and Methods’ section).
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EcoR124I and EcoAI (Figure 7A). The methylation
speciﬁcity of one half site of EcoR124I or EcoAI
corresponds to each putative target adenine residue in
the LlaGI site. pHH-7 was ﬁrst methylated using full-
length LlaGIDA078 [an endonuclease mutant that cannot
cleave DNA but which has wild type translocation
properties (11)], M.EcoAI or M.EcoR124I (‘Materials
and Methods’ section). Each methylated DNA was then
incubated separately with each endonuclease and the
extent of DNA cleavage ascertained (Figure 7B). In each
case endonuclease activity was almost completely blocked
by the cognate MTase, as expected. (The small amount of
cleavage observed with EcoR124I represents the ineﬃcient
de novo methylation of the Type I MTases.) However,
whilst methylation by EcoR124I had no eﬀect on LlaGI
(and vice versa), the methylation activities of LlaGI and
EcoAI blocked both endonucleases. These results are con-
sistent with methylation by LlaGI of the adenine residue
on the bottom strand at the second base pair (Figure 1C)
but not at the adenine residue on the top strand at the ﬁfth
base pair. Attempts to conﬁrm this result using oligodu-
plexes containing a synthetic N6-methyl deoxyadenosine
residue were unsuccessful (data not shown). This may be
the result of the large amount of adjacent DNA required
for LlaGI activity/binding (noted above).
The data in Figure 7B deals exclusively with the
constant adenine residues found in all the possible
LlaGI recognitions sequences (Figure 3B). For two of
the eight sites (CTCGACG and CTGGACG), there are
Figure 6. Stoichiometry and rate of DNA cleavage by LlaGI. Points are the mean of at least two repeat experiments. Note that where the FLL
product becomes smeared due to end-processing, this can cause an overestimation of the CC band which overlaps with the smear. Similarly, smearing
of the OC intermediate in part C causes the CC and FLL bands to be overestimated. This smearing most likely results from processing of the nicked
DNA to form ssDNA gaps of diﬀerent lengths (e.g. by exonucleolytic digestion from the nick). (A) pHH-3 (Figure 3) was incubated with LlaGI
at the concentrations indicated for 1hr. (B) As (A) except in the presence of 100mM AdoMet. (C) pHT-12 (Figure 3) was incubated with LlaGI
at the concentrations indicated for 1h. (D) Time course of cleavage of pHH-3 with a saturating concentration of LlaGI (200nM). (E) as (D) except
in the presence of 100mM AdoMet. (F) Time course of cleavage of pHT-12 with a saturating concentration of LlaGI (200nM). Gels labelled as
in Figure 3.
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hemi-methylated. However, for the other six versions of
the site, adenine residues can also be found at one or both
of the degenerate positions. It is possible that these
residues may also be targets for methylation by LlaGI.
Using the library of two-site DNA generated to test the
DNA cleavage activity (Figure 3, ‘Materials and Methods’
section), we monitored the extent of DNA methylation of
each of the eight sites relative to a constant site (Site a,
Figure 3) using [
3H-methyl] AdoMet (Figure 7C,
‘Materials and Methods’ section). All of the eight sites
were methylated to the same extent. The sequence at
site a contains one degenerate adenine (Figure 3B). The
other sites contain either 0, 1 or 2 degenerate adenines.
Therefore, if any of the degenerate residues were targets
we would have expected a two-fold increase or decrease to
be observed on some substrates. As this was not observed,
these data show that all eight LlaGI sites were methylated
at the same single adenine, i.e. LlaGI only hemi-
methylates DNA regardless of the recognition sequence.
Note, the data in Figure 7B also shows that hemi-
methylation of only one of the two sites (by pre-treatment
with M.EcoAI) is suﬃcient to prevent dsDNA cleavage
(but not the Site a-dependent nicking activity).
DISCUSSION
Our characterisation of the DNA cleavage and
methylation activities of the single polypeptide RM
enzyme LlaGI shows that whilst this enzyme shares
some features with the classical Type I RM enzymes, it
also has activities and features in common with Type II
and III RM enzymes.
(i) The 7-nt DNA recognition sequence of LlaGI
(Figure 1C) is distinct from the bipartite sequences
of the classical Type I enzymes [e.g. GAANNNNN
NRTCG for EcoR124I, where R is any purine, (2)].
This is perhaps unsurprising, given that bioinfor-
matics analysis does not indicate the presence of
an HsdS (or half HsdS) domain in LlaGI. Where
some Type II enzymes contain HsdS-like domains
they also recognise bipartite sequences (2). The
LlaGI recognition sequence is also distinct from
the short asymmetric sequences of the Type III
enzymes which are 6bp or less in length and do
not contain degenerate base pairs [e.g. CTGATG
for PstII (2,24)]. However, similar seven base pair
semi-redundant sequences have been identiﬁed for
some ATP-independent, single polypeptide Type
IIS RM enzymes [e.g. CGRGGAC for RpaB5I
and CAAGNAC for DraRI, (2)]. Outside of
highly conserved MTase amino acid motifs, there
does not appear to be any sequence relationship
between LlaGI and these enzymes (data not shown).
(ii) LlaGI only hemi-methylates its recognition
sequences (Figure 7) which could cause a problem
following semi-conservative replication as
unmethylated sites will occur on the daughter
Figure 7. Methylation speciﬁcity of LlaGI. (A) Plasmid pHH-7 (Figure 3) showing the overlapping EcoAI (blue), LlaGI (bold and yellow) and
EcoR124I (red) sequences at Site b. Adenine residues methylated by EcoAI and EcoR124I are indicated by blue and red circles, respectively (2).
(B) pHH-7 was treated with LlaGIDA078 (L), M.EcoAI (A) or M.EcoR124I (R), as indicated, in the presence of AdoMet. These DNA substrates were
then treated with LlaGI (L), EcoAI (A) or EcoR124I (R), as indicated, in the presence of ATP and AdoMet. The DNA was then separated by
agarose gel electrophoresis. See ‘Materials and Methods’ section and main text for full details. Note, cleavage by all three enzymes produces linear
DNA that is further processed to generate a DNA smear. (C) pZero, pOne and pHH 1,  2,  3,  6,  8,  9,  13 and  14 (Figure 3) were
incubated with LlaGIDA078 and [
3H-methyl] AdoMet for 1h. The extent of
3H-labelling of each site was then assessed by scintillation counting
(‘Materials and Methods’ section). For each plasmid, the labelling at each site was corrected for the gel background and the background from the
corresponding fragments of pZero. Values were then normalised relative to Site a of pOne. These values are presented as a linear scale where positive
values indicate increased labelling relative to Site a and negative values indicate reduced labelling relative to Site a. In pOne the region of Site b is
random DNA and therefore acts as a non-speciﬁc control. The value of this should tend towards an inﬁnitely small negative value. The observed
value of   6 therefore suggests a small background labelling of non-speciﬁc sites when a speciﬁc site is present on the DNA (i.e. the background
labelling is higher than on pZero). In each plasmid the sequence at Site a is the same. Therefore, the values should all be zero, as in plasmid pOne.
Given that the values for Sites a and b were very similar on each DNA, small variations between plasmids most likely represent diﬀerent eﬃciencies
of methylation that arise from variations in DNA preparation quality. Error bars represent the standard error from three repeat experiments.
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feature of all Type III enzymes studied to date
whereas in contrast, the Type I enzymes methylate
both DNA strands (2). Where ATP-independent
Type II enzymes recognise an asymmetric
sequence, methylation of both DNA strands is
achieved by using either two separate, independent
MTases (e.g. HphI), or a single polypeptide that is
the fusion of two independent MTases (e.g. FokI)
(2). More recently however, the single polypeptide
Type IIS RM enzyme MmeI and related enzymes
have been identiﬁed that can only hemi-methylate
their recognition sequences (e.g. TCCRAC for
MmeI, where the adenine underlined is modiﬁed
whilst the adenine complementary to the ﬁrst T
residue is not) (2,9,34). The consequences of hemi-
methylation are considered in more detail below.
(iii) Whilst a DNA nicking activity is observed in the
presence of a single LlaGI site, full dsDNA
cleavage only occurs when two LlaGI sites are
present in a head-to-head orientation (Figures 3
and 4). This is diﬀerent to the classical Type I
enzymes where dsDNA cleavage is independent of
the relative site orientation (27), and only requires a
single site on circular DNA (35). Instead the activity
is more similar to the Type III enzymes (5,24,32,33).
It has been suggested that the requirement for site
orientation speciﬁcity by Type III enzymes is the
direct consequence of the incomplete methylation
of the recognition site (32). By requiring the
presence of two indirectly repeated sites, at least
one of the pair remains hemi-methylated following
replication (Figure 8). We directly demonstrate
here that methylation of one LlaGI site of a pair
is suﬃcient for protection from dsDNA cleavage
(Figure 7B). We suggest that the requirement for a
pair of directional sites for DNA cleavage by LlaGI
evolved to compensate for the incomplete methyla-
tion of the site that would otherwise result in lethal
dsDNA breaks. However, the single unmethlyated
site still results in DNA nicking. Whilst not as
lethal as a dsDNA break, nicks could result in
fork arrest if they are not repaired before the next
round of replication (36).
Although LlaGI and the Type III enzymes share
the same requirement for ATP hydrolysis and a pair
of indirectly-repeated recognition sites, LlaGI
cleaves at random loci in the DNA between a pair
of head-to-head sites whilst the Type III enzymes
cleave  25–27bp downstream of one or other site
(2). The random cleavage proﬁle of LlaGI is very
similar to the distributive cleavage pattern of the
classical Type I enzymes (26,27), which results
from the convergent collision of enzymes that are
translocating from the sites (28). In the accompany-
ing manuscript we demonstrate that LlaGI has
ATPase and loop translocation activities similar to
that of the classical Type I RM enzymes and quite
distinct to the Type III RM enzymes (10,11).
However, whilst the classical Type I enzymes trans-
locate bidirectionally from their sites (37), LlaGI
catalyses unidirectional translocation. A model
for how translocation leads to DNA cleavage is
illustrated in the accompanying paper (10).
(iv) The DNA cleavage proﬁles shows that nicked DNA
is a major intermediate during dsDNA cleavage
(Figure 6). A similar accumulation of nicked DNA
is seen for some classical Type I enzymes, except
that the maximum percentage observed is usually
<33% (35, Frank Peske unpublished observations).
Type III RM enzymes accumulate virtually no
nicked DNA intermediate (30), which is most
likely related to the rate-limiting ATPase activity
that precedes DNA cleavage (33). Since we show
in the accompanying manuscript that LlaGI com-
municates between its sites using a mechanism
similar to that of the classical Type I enzymes
(10), the diﬀerences in the reaction proﬁles most
likely reﬂects diﬀerences in the DNA cleavage
steps rather than communication steps. In the
third accompanying manuscript (11) we show that
LlaGI uses an Mrr nuclease domain distinct to the
RecB-family nuclease domain of the classical Type I
RM enzymes. Although both are part of the PD(D/
E)xK superfamily of nucleases (3), it is possible that
dsDNA cleavage proceeds by diﬀerent mechanisms.
From the data in this paper and the accompanying
manuscripts (10,11), we can compare the domain structure
and enzyme activities of LlaGI to that of Type I, II and III
RM enzymes (Table 2). The Type II RM enzymes
represent a diverse class with varied domain/subunit
architectures and a broad repertoire of enzyme activities.
Here we have chosen to only compare a sub-grouping that
are most similar to LlaGI, the Type IIL enzymes, as
exempliﬁed by MmeI (34). Whilst some features of
Figure 8. The consequences of recognition site hemi-methylation
following replication, adapted from the model of Meisel et al (32,33).
The LlaGI site is indicated as an arrowhead (Figure 1C), the
methylated site by a circle and the newly synthesised DNA in red.
(A) Where two sites are in head-to-head repeat, one site of the pair
is methylated in each of the daughter DNAs and both are protected
from dsDNA cleavage (Figure 7). (B) With two sites in head-to-tail
repeat, both sites in one daughter DNA are completely unmethylated.
However, this arrangement of sites does not result in a dsDNA break
(Figures 3 ands 4). DNA nicking that result from the unmethylated
sites is likely to be repaired before the replication fork next passes.
Nucleic Acids Research, 2009,Vol.37, No. 21 7215LlaGI activity are clearly Type I-like (the presence of
similar helicase and MTase domains, an extensive
ATPase activity, dsDNA loop translocation, distributive
non-speciﬁc DNA cleavage loci), others are Type III-like
(a requirement for two sites with a particular orientation,
single-strand methylation) or Type IIL-like (short degen-
erate recognition sequence, single-strand methylation,
single polypeptide multi-domain arrangement). The clas-
siﬁcation of Type I and III enzymes was historically on the
basis of gene arrangement (Type I enzymes comprising
HsdS, HsdM and HsdR subunits, Type III enzymes
comprising Mod and Res subunits). Subsequent biochem-
ical analysis has shown that both Types have enzyme
behaviour that is largely family-speciﬁc and distinct. We
suggest that given the presence of a helicase domain that
couples extensive ATP hydrolysis to loop translocation
(10), LlaGI is most closely related to the Type I enzymes
and should be classiﬁed as such. However, to distinguish
the single polypeptide enzymes from the classical multi-
subunit enzymes, we suggest the nomenclature Type I SP
(for single polypeptide). This avoids confusion with
the single letter suﬃces that have already been assigned
to sub-families of Type I enzymes from enterobacteria
(on the basis of gene complementation and antibody
cross-reactivity) and to the Type II enzymes (on
the basis of gene and enzyme properties) (38). Our classi-
ﬁcation redeﬁnes the Type I enzymes in more general
terms as dsDNA loop translocases that cleave DNA at
random sites distant from their recognition sequences.
The classiﬁcation of the Type III enzymes remains open
to discussion, as DNA looping, DNA loop translocation,
DNA translocation and bi-directional DNA sliding
models have all been proposed and a consistent mecha-
nism has yet to emerge.
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Table 2. Genetic and biochemical classiﬁcation of LlaGI
Type I Type III Type IIL Type ISP
e.g. EcoR124I e.g. EcoPI e.g. MmeI e.g. LlaGI
Genes/protein
Genes HsdR, hsdM, hsdS Res, mod RM RM
Nuclease Complex R2M2S1 Res2Mod2 n.d. RM1 (RM2 for cleavage?)
Recognition sequence Asymmetric, bipartite
GAAnnnnnnRTCG
Short, asymmetric
AGACC
Short, asymmetric,
degenerate
TCCrAC
Short, asymmetric,
degenerate
CTnGAyG
DNA methylation
Methylation Both strands One strand One strand One strand
DNA cleavage
Cofactors ATP, Mg
2+, AdoMet ATP, Mg
2+ Mg
2+ ATP, Mg
2+
Multiple sites required? Yes, Linear DNANo,
circular DNA
Yes (+AdoMet)
No (-AdoMet)
a
Yes Yes (dsDNA break)
No (nicking)
Sites required in cis? Yes Yes No Yes
Communication mode 1D 1D 3D 1D
Preference for site directionality? None Indirect repeat
b None Indirect Repeat
(head-to-head only)
Cleavage loci? Non-speciﬁc random Non-speciﬁc Non-speciﬁc Non-speciﬁc random
Distant and proximal Fixed proximal Fixed proximal Distant and proximal
Helicase motor activity No helicase domain
DNA Loop translocation required Yes No Yes
DNA Supercoiling Yes No Yes
Directionality Bidirectional (two
unidirectional motors
per complex)
Bidirectional
b Unidirectional
Translocation rate 463bp/s (20 C) n.d. 173 ATP/s (20 C)
ATPase rate 503 ATP/s/motor(20 C)  0.2 ATP/s/per
complex (20 C)
250 ATP/s (20 C)
ATP per bp 1–1.5 «1 1.5–2
Step size 1–2 n.d. n.d.
Average distance moved per event  5000bp n.d. n.d.
Motor polarity 30–50 n.d. n.d.
Triplex displacement Yes No Yes
Data for EcoR124I was collated from refs (14,27,35,39–41). Data for EcoPI was collated from refs (30,42–45). Data for MmeI was collated from refs
(2,9,34). Data for LlaGI was from this paper and refs. 1,10,11. n.d. is where data is not determined.
aRelaxed cleavage conditions with high enzyme:DNA ratios.
bDogma states that Type III enzymes only cut sites in head-to-head repeat (33) but more recent analysis suggests that tail-to-tail repeats are cut
equally well (Kara van Aelst, M.D.S. and Ralf Seidel, unpublished data).
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